sumatriptan succinate and naproxen sodium · Tablet

What changed in the last 90 days

Every detected change for sumatriptan succinate and naproxen sodium, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Serotonin-1b and Serotonin-1d Receptor Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• eletriptan hbr· 1 maker
• meloxicam, rizatriptan· 1 maker
• almotriptan· 2 makers
• rizatriptan benzoate odt· 2 makers
• sumatriptan and naproxen sodium· 3 makers
• almotriptan malate· 4 makers
• naratriptan· 4 makers
• rizatriptan· 6 makers
• frovatriptan succinate· 8 makers
• eletriptan hydrobromide· 14 makers
• zolmitriptan· 30 makers
• sumatriptan· 34 makers

Common questions

Is Sumatriptan succinate and naproxen sodium in shortage right now?

No. FDA does not currently list Sumatriptan succinate and naproxen sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Sumatriptan succinate and naproxen sodium?

2 companies have marketed Sumatriptan succinate and naproxen sodium in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.